West Pharmaceutical Services Inc.
Net Cash Flow Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
Total Cash from Operations: $730.2M
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $284.6M | 39.0% |
| Other Investing | $3.6M | 0.5% |
| Dividends Paid | $54.1M | 7.4% |
| Stock Repurchases | $202.8M | 27.8% |
| Other Financing | $36.7M | 5.0% |
| Working Capital | $6.2M | 0.8% |
| Other | $10.5M | 1.4% |
| Net Cash Flow | $131.7M | 18.0% |